Takeda Pharmaceutical
TAK
#451
Rank
NZ$95.14 B
Marketcap
NZ$29.79
Share price
0.57%
Change (1 day)
22.65%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2026 (TTM): NZ$0.28 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are NZ$29.73 Billion. In 2025 the company made an earning of NZ$5.64 Billion, an increase over its 2024 earnings that were of NZ$3.78 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.28 B-95.02%
2025 NZ$5.64 B49.03%
2024 NZ$3.78 B-2.41%
2023 NZ$3.88 B-28.14%
2022 NZ$5.40 B-40.9%
2021 NZ$9.13 B78.24%
2020 NZ$5.12 B246.1%
2019 NZ$1.48 B-48.79%
2018 NZ$2.89 B-23.64%
2017 NZ$3.78 B21.7%
2016 NZ$3.11 B-253.01%
2015 -NZ$2.04 Billion-159.65%
2014 NZ$3.41 B13%
2013 NZ$3.01 B2.46%
2012 NZ$2.94 B-57.05%
2011 NZ$6.85 B-10.49%
2010 NZ$7.66 B-3.99%
2009 NZ$7.97 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.10 B 9,308.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$26.79 B 5,616.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$17.97 B 3,735.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.42 B 3,190.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.00 B 2,673.61%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$22.32 B 4,663.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$16.99 B 3,525.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-NZ$1.35 Billion-386.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
NZ$1.12 B 140.37%๐Ÿ‡ฎ๐Ÿ‡ณ India